Table 1

Qualitative data for patients who developed an infection (n = 28).

Variable n (%)
Gender
 Men8 (28.6)
 Women20 (71.4)
Revision surgery
 Yes9 (32.1)
 No19 (67.9)
Area
 Thoracic spine2 (7.1)
 Lumbar spine20 (71.4)
 Thoracolumbar spine6 (21.4)
No. of segments fused
 210 (35.7)
 311 (39.3)
 45 (17.9)
 52 (7.1)
Antibiotic prophylaxis
 Cefazolin17 (60.7)
 Vancomycin1 (3.6)
 Cefazolin + aminoglycoside7 (25.0)
 Cefazolin + gentamicin + rifampicin2 (7.1)
 Unspecified1 (3.6)
Obesity (by body mass index [kg/m2])
  <3012 (46.2)
 30–3512 (46.2)
  >352 (7.7)
Smoking
 Yes1 (3.6)
 No27 (96.4)
Malnutrition
 No28 (100)
American Society of Anesthesiologists class
 I10 (35.7)
 III–IV18 (64.3)
History of infection
 Yes1 (3.6)
 No27 (96.4)
Time at which infection occurred
 Early28 (100)
Infection level
 Deep28 (100)
Bacteria
 Gram-positive11 (39.3)
 Gram-negative7 (25.0)
 Mixed10 (35.7)
Sonication
 Performed2 (7.4)
 Not performed25 (92.6)
Pathogen concordance
 Yes13 (46.4)
 No15 (53.6)
Surgical procedure performed
 Debridement with instrument retention/replacement27 (96.4)
 Complete removal1 (3.6)
No. of irrigations
 13 (46.4)
 22 (42.9)
 31 (3.6)
 41 (3.6)
 61 (3.6)
Status at 2 year follow-up evaluation
 Infection cured with debridement23 (82.1)
 Infection cured with hardware replacement4 (14.8)
 Treatment failure1 (3.6)
Plastic surgery
 Yes4 (14.3)
 No24 (85.7)
Vacuum-assisted closure therapy
 Yes6 (21.4)
 No22 (78.6)